International HIV/Viral Hepatitis Co-Infection Satellite Meeting
 
Meeting Program (subject to change)
18/07/2014
8:00 am - 8:45 amRegistration
Pre-Function Area
8:45 am - 10:30 amHCV Therapeutic Development and Access [More Info]
Rialto Room 1 & 2
Chairperson: Greg Dore, (Co-Convenor) Kirby Institute
Chairperson: Juergen Rockstroh
8:45 am - 9:00 amIntroductions [More Info]
Rialto Room 1 & 2
Greg Dore, (Co-Convenor) Kirby Institute
9:00 am - 9:30 amGlobal HIV/Viral Hepatitis Co-infection: Epidemic Trends and Disease Burden [More Info]
Rialto Room 1 & 2
Keynote Speaker: Philippa Easterbrook, WHO
9:30 am - 10:00 amA New Era of HCV Clinical Management [More Info]
Rialto Room 1 & 2
Keynote Speaker: Mark Sulkowski, Johns Hopkins University
10:00 am - 10:30 amHuman Rights and Access to New HCV Therapies [More Info]
Rialto Room 1 & 2
Keynote Speaker: Edo Agustian, PKNI (Persaudaraan Korban Napza Indonesia)
10:30 am - 11:00 amBreak
Pre-Function Area
11:00 am - 12:30 pmControlling HBV Infection and Disease Burden [More Info]
Rialto Room 1 & 2
Chairperson: Marion Peters
Chairperson: Sanjay Baghani, Royal Free Hospital
11:00 am - 11:30 amImpact of Antiretroviral Therapy on HBV Liver Disease Burden [More Info]
Rialto Room 1 & 2
Keynote Speaker: Chloe Thio, Johns Hopkins University
11:30 am - 12:00 pmGlobal Antiretroviral Therapy Delivery as a Foundation for Access to HBV Therapy [More Info]
Rialto Room 1 & 2
Keynote Speaker: Mark Sonderup, University of Cape Town & Groote Schuur Hospital
12:00 pm - 12:30 pmExperiences with the Successful Scale up of HBV Birth Dose Vaccination [More Info]
Rialto Room 1 & 2
Keynote Speaker: Jidong Jia, Beijing Friendship Hospital, Capital Medical University
12:30 pm - 1:30 pmLunch
Pre-Function Area
1:30 pm - 3:00 pmNatural History and Management of HCV Across the Disease Spectrum [More Info]
Rialto Room 1 & 2
Chairperson: Gail Matthews, Kirby Institute
Chairperson: Mark Sulkowski, Johns Hopkins University
1:30 pm - 2:00 pmAcute HCV Infections and Re-infections in HIV+ MSM: Debunking the Myths [More Info]
Rialto Room 1 & 2
Keynote Speaker: Mark Danta, St Vincent's Hospital
2:00 pm - 2:30 pmEvolving HCV Morbidity and Mortality in the Era of Combination Antiretroviral Therapy [More Info]
Rialto Room 1 & 2
Keynote Speaker: Karine Lacombe, Hôpital Saint-Antoine
2:30 pm - 3:00 pmRole of Ribavirin in New Era of HCV Therapy [More Info]
Rialto Room 1 & 2
Keynote Speaker: Jordan Feld, University of Toronto
3:00 pm - 3:30 pmBreak
Pre-Function Area
3:30 pm - 5:00 pmWorkshop - Implementation of Viral Hepatitis Programs in Low and Middle Income Countries [More Info]
Rialto Room 1 & 2
Moderator: Isabelle Andrieux - Meyer, MSF
International AIDS Conference Abstract Session [More Info]
Wheat & Wool Room
Chairperson: Greg Dore, (Co-Convenor) Kirby Institute
Chairperson: Juergen Rockstroh
3.30pm - 3.45pm WHO HCV Treatment Guidelines: Priorities for Implementation [More Info]
Rialto Room 1 & 2
Keynote Speaker: Margaret Hellard, Burnet Institute
3.30pm - 3.50pm Activation of Hepatic Stellate Cells Drives the Rapid Onset of Liver Fibrosis During Acute HCV Infection in HIV-infected Men (2514) [More Info]
Wheat & Wool Room
Daniel Fierer, Mount Sinai Hospital
3.45pm - 4.00pm Viral Hepatitis Treatment for People with HIV in Asia [More Info]
Rialto Room 1 & 2
Keynote Speaker: Anchalee Avihingsanon, HIV-NAT
3.50pm - 4.10pm Low Frequency of Anemia in Phase 3 Trials of ABT-450/r/ABT-267 and ABT-333 With Ribavirin in Treatment-Naïve (SAPPHIRE-I) and Treatment-Experienced (SAPPHIRE-II) Patients (699) [More Info]
Wheat & Wool Room
Mark Sulkowski, Johns Hopkins University
4.00pm - 4.15pm Viral Hepatitis Treatment for People With HIV in African Settings [More Info]
Rialto Room 1 & 2
Mark Sonderup, University of Cape Town & Groote Schuur Hospital
4.10pm - 4.30pm 11391 Ledipasvir/Sofosbuvir is Safe and Effective as a Single-Tablet-Regimen for Treatment of Patients with Genotype 1 Chronic Hepatitis C Virus, Including those with Compensated Cirrhosis [More Info]
Wheat & Wool Room
Mark Sulkowski, Johns Hopkins University
4.30pm - 5.00pm Panel Discussion [More Info]
Rialto Room 1 & 2
Panellist: Olga Stefanishina, Patient's Group (formerly UCAB)
Panellist: Margaret Hellard, Burnet Institute
Panellist: Anchalee Avihingsanon, HIV-NAT
Mark Sonderup, University of Cape Town & Groote Schuur Hospital
4.30pm - 5.00pm Panel Discussion [More Info]
No location
Mark Sulkowski, Johns Hopkins University
Daniel Fierer, Mount Sinai Hospital
Ed Gane, Auckland City Hospital
Jordan Feld, University of Toronto
5:00 pm - 6:00 pmWelcome Drinks
Pre-Function Area

19/07/2014
8:00 am - 9:00 amRegistration
Pre-Function Area
9:00 am - 10:30 amOptimising HCV Treatment Access and Outcomes [More Info]
Rialto Room 1 & 2
Chairperson: Tracy Swan, Treatment Action Group
Chairperson: Philippa Easterbrook, WHO
9:00 am - 9:30 amAccess to IFN-Free DAA Treatment: Lessons From ART Access Strategies [More Info]
Rialto Room 1 & 2
Keynote Speaker: Nathan Ford, WHO
9:30 am - 10:00 amWhat is the minimum cost to cure Hepatitis C? [More Info]
Rialto Room 1 & 2
Keynote Speaker: Andrew Hill, University of Liverpool
10:00 am - 10:30 am HCV Treatment as Prevention: Feasible or Forlorn? [More Info]
Rialto Room 1 & 2
Keynote Speaker: Peter Vickerman, University of Bristol
10:30 am - 11:00 amBreak
Pre-Function Area
11:00 am - 12:30 pmComplex Issues in Viral Hepatitis Management [More Info]
Rialto Room 1 & 2
Chairperson: Ben Cowie, Royal Melbourne Hospital
Chairperson: Karine Lacombe, Hôpital Saint-Antoine
11:00 am - 11:30 amEpidemiology and Management of HCC Among People With HIV [More Info]
Rialto Room 1 & 2
Keynote Speaker: David Iser, St. Vincent’s Hospital
11:30 am - 12:00 pmFuture HCV Therapeutic Strategies for Non-1 Genotype Infection [More Info]
Rialto Room 1 & 2
Keynote Speaker: Ed Gane, Auckland City Hospital
12:00 pm - 12:30 pmRole of IFN-Based Therapy for HCV in the Asian Region [More Info]
Rialto Room 1 & 2
Keynote Speaker: Wei Lai, Peking University People’s Hospital
12:30 pm - 1:30 pmLunch
Pre-Function Area
1:30 pm - 3:00 pmWorkshop: Pushing the Envelope in Acute HCV Treatment [More Info]
Rialto Room 1 & 2
Chairperson: Gail Matthews, Kirby Institute
Moderator: Tracy Swan, Treatment Action Group
Workshop: Screening and Assessment for HBV and HCV Among People with HIV [More Info]
Wheat & Wool Room
Moderator: Philippa Easterbrook, WHO
Moderator: Isabelle Andrieux - Meyer, MSF
1.30pm - 1.50pm Acute HCV Treatment - Germany Perspective [More Info]
Rialto Room 1 & 2
Keynote Speaker: Chris Boesecke, University of Bonn
1.30pm - 1.35pm Introduction to Session and Overview of Guidelines [More Info]
Wheat & Wool Room
Moderator: Philippa Easterbrook, WHO
1.50pm - 2.10pm Acute HCV Treatment - USA Perspective [More Info]
Rialto Room 1 & 2
Keynote Speaker: Daniel Fierer, Mount Sinai Hospital
1.35pm - 1.50pm Diagnostics for Viral Hepatitis – WHO Prequalification of Diagnostics Programme [More Info]
Wheat & Wool Room
Anita Sands, WHO
2.10pm - 2.30pm Acute HCV Treatment - Australian Perspective [More Info]
Rialto Room 1 & 2
Keynote Speaker: Gail Matthews, Kirby Institute
1.50pm - 2.05pm Perspectives from the field – diagnostic algorithms for scale-up of screening in MSF programme [More Info]
Wheat & Wool Room
Teri Roberts, MSF
2.30pm - 3.00pm Panel Discussion [More Info]
Rialto Room 1 & 2
Panellist: Chris Boesecke, University of Bonn
Panellist: Daniel Fierer, Mount Sinai Hospital
Panellist: Gail Matthews, Kirby Institute
Panellist: Sanjay Baghani, Royal Free Hospital
Chris Ward, EATG
Dr Robert Finlayson, Taylor Square Private Clinic
Ben Wilcock, Australian Federation of AIDS Organisations
2.05pm - 2.20pm Liver fibrosis assessment in resource-limited settings [More Info]
Wheat & Wool Room
Karine Lacombe, Hôpital Saint-Antoine
2.20pm - 3.00pm Panel discussion
Wheat & Wool Room
3:00 pm - 3:30 pmBreak
Pre-Function Area
3:30 pm - 5:30 pmPublic Health Advocacy and Access to HCV Therapy [More Info]
Rialto Room 1 & 2
Chairperson: Isabelle Andrieux - Meyer, MSF
Moderator: Tracy Swan, Treatment Action Group
3:30 pm - 3:50 pmCommunity-Based Organisations Role in Global Advocacy for HCV Therapy [More Info]
Rialto Room 1 & 2
Keynote Speaker: Karyn Kaplan, Treatment Action Group
3:50 pm - 4:10 pmHuman Rights and Antiviral Therapy Access [More Info]
Rialto Room 1 & 2
Keynote Speaker: Michael Kirby, Patron, Kirby Institute
4:10 pm - 5:20 pmPanel Discussion [More Info]
Rialto Room 1 & 2
Panellist: Isabelle Andrieux - Meyer, MSF
Panellist: Daniel Wolfe, Open Society Foundations
Panellist: Colleen Connell, CHAI
Panellist: Gottfried Hirnschall, WHO
Panellist: Gregg Alton, Gilead
Panellist: Michel Kazatchkine, UN Secretary General on HIV/AIDS in Eastern Europe and Central Asia
Panellist: Edo Agustian, PKNI (Persaudaraan Korban Napza Indonesia)
Moderator: Norman Swan, ABC Radio National
Panellist: Michael Kirby, Patron, Kirby Institute
Panellist: Karyn Kaplan, Treatment Action Group
Panellist: Adrian Thomas, Janssen
Brenda Waning, WHO
5:20 pm - 5:30 pmClosing Remarks [More Info]
Rialto Room 1 & 2
Juergen Rockstroh